Why is Humanwell Healthcare (Group) Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.21% and Operating profit at 0.11% over the last 5 years
2
Flat results in Sep 25
- OPERATING CASH FLOW(Y) Lowest at CNY 2,364.32 MM
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.16 times
- NET SALES(Q) Lowest at CNY 5,819.43 MM
3
With ROE of 9.29%, it has a fair valuation with a 1.88 Price to Book Value
- Over the past year, while the stock has generated a return of -2.94%, its profits have fallen by -33.7%
- At the current price, the company has a high dividend yield of 2.2
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -2.94% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Humanwell Healthcare (Group) Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Humanwell Healthcare (Group) Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Humanwell Healthcare (Group) Co., Ltd.
-8.03%
0.10
27.09%
China Shanghai Composite
15.17%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
3.21%
EBIT Growth (5y)
0.11%
EBIT to Interest (avg)
6.19
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.90
Tax Ratio
25.83%
Dividend Payout Ratio
57.69%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.69%
ROE (avg)
14.85%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.88
EV to EBIT
16.03
EV to EBITDA
11.11
EV to Capital Employed
1.70
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
2.23%
ROCE (Latest)
10.63%
ROE (Latest)
9.29%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -7.82% (YoY
NET PROFIT(9M)
Higher at CNY 1,691.08 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 23.67 %
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 2,364.32 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.16 times
NET SALES(Q)
Lowest at CNY 5,819.43 MM
Here's what is working for Humanwell Healthcare (Group) Co., Ltd.
Debt-Equity Ratio
Lowest at 23.67 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Profit
Higher at CNY 1,691.08 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -7.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Humanwell Healthcare (Group) Co., Ltd.
Operating Cash Flow
Lowest at CNY 2,364.32 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 5,819.43 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 2.16 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






